Results 11 to 20 of about 8,552 (200)

Liquisolid Tablets Formulation of Atorvastatin Calcium Using Polyethylene Glycol 400 as Solvent and Some Carrier Materials

open access: yesIndonesian Journal of Pharmacy, 2020
The dissolution of atorvastatin calcium need to be improved since included BCS Class II drugs with low solubility and high permeability, meaning that the dissolution affects the bioavailability of drugs.
Yulias Ninik Windriyati   +3 more
doaj   +1 more source

Pulmonary Covid fibrosis a new pharmaceutic approach

open access: yesInternational Journal of Preventive Medicine, 2021
Background: Patient's post-COVID may develop chronic irreversible respiratory failure with “widespread signs of pulmonary fibrosis.” Our study analyzed the causes of this fibrosis to propose a therapeutic protocol.
Roberto Menicagli   +4 more
doaj   +1 more source

Pharmaceutical Biotechnology

open access: yesLife, 2022
Biotechnology and pharmacy have shown efficient results when combined to generate innovative technological products [...]
Cesar Augusto Roque-Borda   +2 more
openaire   +3 more sources

HyperLoom: A platform for defining and executing scientific pipelines in distributed environments [PDF]

open access: yes, 2018
Real-world scientific applications often encompass end-to-end data processing pipelines composed of a large number of interconnected computational tasks of various granularity.
Ashby, Thomas J.   +7 more
core   +1 more source

Virtual screening of Osimertinib and Dacomitinib Analogues with potential activity on EGFR (T790M and l858R Mutations) for non-small cell lung cancer treatment

open access: yesRevista Ciencias Biomédicas, 2021
Introduction: Tyrosine kinase inhibitors (TKIs) drugs act on epidermal growth factor (EGFR) receptors to treat Non-small cell lung cancer (NSCLC). However, mutations on EGFR receptors T790M and L858R allow just a global response rate (GRR) of 80% with ...
Leydis Luna Torres   +2 more
doaj   +1 more source

IMI – industry guidelines and ethical considerations for myopia control report [PDF]

open access: yes, 2019
PURPOSE. To discuss guidelines and ethical considerations associated with the development and prescription of treatments intended for myopia control (MC). METHODS.
Drove, Bjorn   +16 more
core   +1 more source

Synthesis of Scutellarein Derivatives with a Long Aliphatic Chain and Their Biological Evaluation against Human Cancer Cells

open access: yesMolecules, 2018
Scutellarin is the major active flavonoid extracted from the traditional Chinese herbal medicine Erigeron breviscapus (Vant.) Hand-Mazz., which is widely used in China. Recently, accumulating evidence has highlighted the potential role of scutellarin and
Guanghui Ni   +4 more
doaj   +1 more source

Development of a UV−Vis Spectroscopy Method Allied with Chemometrics for Simultaneous Analysis of Dexketoprofen Trometamol and Thiocolchicoside in Commercial Tablets

open access: yesTrends in Pharmacy
Background: Herein, a simple UV–Vis spectrophotometric method coupled with che mometrics including principal component analysis (PCA) and partial least squares (PLS) regression/prediction analysis was utilized for the simultaneous determina tion of ...
Nilay Öncel   +3 more
doaj   +5 more sources

Identification of atropine-and P2X1 receptor antagonist-reistant, neurogenic contractions of the urinary bladder [PDF]

open access: yes, 2007
Acetylcholine and ATP are excitatory cotransmitters in parasympathetic nerves. We used P2X1 receptor antagonists to further characterize the purinergic component of neurotransmission in isolated detrusor muscle of guinea pig urinary bladder.
Gallagher, Gemma   +3 more
core   +1 more source

In silico analysis and preclinical findings uncover potential targets of anti-cervical carcinoma and COVID-19 in laminarin, a promising nutraceutical

open access: yesFrontiers in Pharmacology, 2022
Until today, the coronavirus disease 2019 (COVID-19) pandemic has caused 6,043,094 deaths worldwide, and most of the mortality cases have been related to patients with long-term diseases, especially cancer.
Jiaqi Liu   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy